Business Standard
Friday, Jun 01, 2012
Sponsored by  
drived banner
drived banner
  Advanced Search
RSS
Content Guide
Follow us on  
||||Economy & Policy||||| 
 Section Home | News Now | Today's Paper | Features & Analysis | Politics & Public Affairs | Q&A | Columnists | BS Says
Home > Economy & Policy Live Markets | Commodities
 

Vaccine cuts HIV infection for first time: researchers
Press Trust of India / Washington Sep 24, 2009, 16:06 IST

In a breakthrough, researchers have for the first time have found a vaccine that cuts HIV infection by more than 31 per cent, giving fresh boost to the global fight against the dreaded disease.

The experimental drug cuts the risk of HIV infection by a third in the world's largest AIDS trial of more than 16,000 volunteers in Thailand, researchers said.

It is the first time after two decades of human trials that a vaccine has stopped the virus infecting 7,500 across the world every day.

"It gives me cautious optimism about the possibility of improving this result and developing a more effective AIDS vaccine," Anthony Fauci, director of the United States National Institute of Allergy and Infectious Diseases was quoted by Washington Post.

Colonel Jerome Kim, led the study for the US Army, which was also involved in the trial, said, "It is the first evidence that we could have a safe and effective preventive vaccine."

The vaccine, a complicated mixture of six "prime" and "booster" shots, is the first positive result after two decades of experimentation.

"Conceptually, we now know a vaccine is possible," said Fauci, adding, "Whether the vaccine is going to look anything like this one I don't know. But at least we know it can be done."

The trail run for the vaccine for the last six years has been jointly conducted by the US Army, the Thai Ministry of Public Health, NIAID institute, and two other patent holder companies.

The finding is statistically significant with 31.2 per cent effectiveness but scientists seldom consider licensing a vaccine which is less than 70 or 80 per cent effective.

Instead, the chief benefit of the ALVAC-AIDSVAX vaccine is that it can give fresh insights into the human immune system specially when a person is protected from HIV.

"We really need to go through the data to see if there are effects here that are potentially useful," said Kim.

New Ipad Application :Business Standard's all new IPad App
Click here to download for free
Arrow Other Stories     
- Markets post worst May performace since 2006
- US jobs data points to recovery losing momentum
- FII-TO-FII TRADES: PNB traded at 5% premium
- Sugar output up at 25.5 million tonne this year surpasses govt estimate
- CoalMin identifies 54 blocks for allocation through auction
  Read Business news in 
- Help a Child Achieve her. Click to know more
- Benefits Upto Rs. 2.36 Lakhs on the Fully Loaded TJet Petrol.
- Watch The Film Here. Click here to know more..
- 1 billion in saving for Unilever without any tangles.
- One Partnership Endless Possibilities. Click here to know more
- Which is the best plan for your daughter
- Check out the TRUE COLOURS of your Stocks, Now for FREE!
- One of the leading business schools in the world.Know More
Sorry, comments to this story are closed
Latest Messages
Table for Two
  Now available at Special price
  Rs.280/- Only

  Buy Now
BS POLL
UPA 2 has completed three years. How do you rate its performance?  Read the story
  Good
  Average
  Bad
Submit
Most Popular
Read
E-Mailed
Commented
   
- Slowdown gets worse, GDP growth sinks to 9-year low
- M&M has a Rs 7,500-cr spending plan over three years
- India Inc ready to shift to other side of the dot on www
- India to be $2-trn economy by FY13-end?
- IIT alumni to move court on changes in JEE
 
 More  
New Ipad Application
 Business Standard's all new IPad  App
 Click here to download for free
  Hot Searches  
 
Apalya |  Air India |  GAAR |  Agni  |  Solar eclipse |  Satyamev Jayate |  SRK |  Aamir Khan |  IPL |  Ertiga |  Sarfaesi Act |  Vodafone |  JP Morgan |  Transfer pricing |  Rupee |  Kingfisher Airlines |  Silver |  Provident Fund |  income tax refund |  iPhone |  Reliance Industries |  SEBI |  BSNL |  BSE |  NSE |  Mukesh Ambani |  Anil Ambani |  Infosys |  Pranab Mukherjee |  Sonia Gandhi |  Rahul Gandhi |  New Pension Scheme |  Reliance |  RBI |  GDP |  Gold |  Ratan Tata |  ICICI |  B-School |  Sensex |  Tax calculator |  Home Loan |  Personal Finance |  inflation |  oil prices |  Barack Obama |   
 
  Member Area Write to the Editor RSS Archives Advanced Search
  Subscribe to BS print product BS e-paper Newsletter Portfolio Tracker
  BS Products BS Hindi BS Motoring BS Books
Home | Markets & Investing | Companies & Industry | Banking & Finance | Economy & Policy | Opinion
Life & Leisure | Management & Marketing | Tech World | General News
About Us | Partner With Us | Code of Conduct | Careers | Advertise with us| Terms & Conditions | Disclaimer | Contact Us